SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-003803
Filing Date
2019-05-02
Accepted
2019-05-02 08:36:16
Documents
55
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20190331x10q.htm 10-Q 1124736
2 EX-10.1 glyc-20190331ex101d8a95a.htm EX-10.1 290150
3 EX-31.1 glyc-20190331ex311a435f1.htm EX-31.1 18157
4 EX-31.2 glyc-20190331ex312be4756.htm EX-31.2 17208
5 EX-32.1 glyc-20190331ex321a4d03b.htm EX-32.1 10260
  Complete submission text file 0001558370-19-003803.txt   4693729

Data Files

Seq Description Document Type Size
6 EX-101.INS glyc-20190331.xml EX-101.INS 867368
7 EX-101.SCH glyc-20190331.xsd EX-101.SCH 31698
8 EX-101.CAL glyc-20190331_cal.xml EX-101.CAL 38103
9 EX-101.DEF glyc-20190331_def.xml EX-101.DEF 128463
10 EX-101.LAB glyc-20190331_lab.xml EX-101.LAB 302298
11 EX-101.PRE glyc-20190331_pre.xml EX-101.PRE 243697
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 19789898
SIC: 2834 Pharmaceutical Preparations